Results for tag: "Leptomeningeal Metastases Drug"

Leptomeningeal Metastases (LM) is a type of brain cancer that occurs when cancer cells spread to the membranes that cover the brain and spinal cord. LM is a serious complication of many types of cancer, including breast, lung, and melanoma. Treatment for LM is challenging, as the cancer cells are often resistant to traditional chemotherapy and radiation. Drugs used to treat LM are typically targeted therapies, such as monoclonal antibodies, small molecule inhibitors, and immunotherapies. These drugs are designed to target specific cancer cells, and can be used in combination with other treatments. In addition, some drugs are being developed to target the underlying cause of LM, such as genetic mutations. The LM drug market is a rapidly growing field, as new treatments are being developed to improve outcomes for patients. Companies in the market include Novartis, Merck, Pfizer, and Roche. Other companies, such as Celgene, are also researching new treatments for LM. Show Less Read more